Hiponatremia en pacientes hospitalizados con insuficiencia cardiaca descompensada en una IPS de Barranquilla
datacite.rights | http://purl.org/coar/access_right/c_16ec | eng |
dc.contributor.advisor | Tafur, Yaneris | |
dc.contributor.author | Chica Valle, David Antonio | |
dc.contributor.author | Roa Silvera, Natalia Carolina | |
dc.contributor.author | Contreras Meriño, Víctor Manuel | |
dc.date.accessioned | 2021-07-17T11:12:14Z | |
dc.date.available | 2021-07-17T11:12:14Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Introducción: La insuficiencia cardiaca (IC) es una de las enfermedades más prevalentes en la población adulta. En Colombia, la tasa de mortalidad por IC es de 9.3 por cada 100.000 habitantes. Se define hiponatremia como la concentración de sodio plasmático < 135 mEq/L. La hiponatremia en pacientes con IC demostró ser un importante predictor de complicaciones y muerte a corto y largo plazo en diversos países, sin embargo, en Colombia no hay suficientes estudios que evalúen la relación de éstas. El objetivo de este trabajo fue evaluar si la hiponatremia en pacientes con insuficiencia cardiaca descompensada representaba un mayor riesgo de mortalidad. Materiales y métodos: Se realizó un estudio de tipo observacional analítico prospectivo longitudinal no experimental en pacientes hospitalizados con diagnóstico de IC descompensada en una IPS de tercer nivel de Barranquilla en el periodo 2019-2 y 2020-1. Resultados: Se estudiaron 51 pacientes, los cuales tuvieron un promedio de edad de 64,2 años, con predominio del 52,9% del sexo femenino. El 74,5% de los pacientes presentaban valores séricos de sodio normal; solo un 21,6% de estos presentaron hiponatremia. Se reportaron 7 muertes, correspondiente a una mortalidad del 13,7%. El riesgo (OR) no ajustado de muerte teniendo niveles séricos de sodio disminuidos al ingreso a hospitalización de los pacientes con insuficiencia cardiaca descompensada es 15 IC (2.350-95.745) veces más, que aquellos que no presentan hiponatremia. Conclusión: La hiponatremia es una alteración frecuente en pacientes hospitalizados y su hallazgo al ingreso se asocia con mayor probabilidad de muerte durante la hospitalización. | spa |
dc.description.abstract | Introduction: Heart failure (HF) is one of the most prevalent diseases in the adult population. In Colombia, the mortality rate for HF is 9.3 per 100,000 inhabitants. Hyponatremia is defined as the plasma sodium concentration <135 mEq / L. Hyponatremia in patients with HF proved to be an important predictor of complications and death in the short and long term in various countries, however, in Colombia there are not enough studies evaluating their relationship. The objective of this work was to evaluate if hyponatremia in patients with decompensated heart failure represented a higher risk of mortality. Materials and methods: A non-experimental longitudinal prospective analytical observational study was conducted in patients study was conducted in hospitalized patients with a diagnosis of decompensated HF in a third-level IPS of Barranquilla in the period 2019-2 and 2020-1. Results: 51 patients were studied, who had an average age of 64.2 years, with a predominance of 52.9% of the female sex. 74.5% of the patients presented normal serum sodium values; only 21.6% of these presented hyponatremia. 7 deaths were reported, corresponding to a mortality of 13.7%. The unadjusted risk (OR) of death with decreased serum sodium levels on admission to hospitalization of patients with decompensated heart failure is 15 CI (2,350-95,745) times more than those without hyponatremia. Conclusion: Hyponatremia is a frequent alteration in hospitalized patients and its finding on admission is associated with a greater probability of death during hospitalization. | eng |
dc.format.mimetype | spa | |
dc.identifier.uri | https://hdl.handle.net/20.500.12442/8011 | |
dc.language.iso | spa | spa |
dc.publisher | Ediciones Universidad Simón Bolívar | spa |
dc.publisher | Facultad de Ciencias de la Salud | spa |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | eng |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Insuficiencia cardiaca | spa |
dc.subject | Hiponatremia | spa |
dc.subject | Péptidos natriuréticos | spa |
dc.subject | Mal pronóstico | spa |
dc.subject | Mortalidad | spa |
dc.subject | Heart failure | eng |
dc.subject | Hyponatremia | eng |
dc.subject | Natriuretic peptides | eng |
dc.subject | Bad prognosis | eng |
dc.subject | Mortality | eng |
dc.title | Hiponatremia en pacientes hospitalizados con insuficiencia cardiaca descompensada en una IPS de Barranquilla | spa |
dc.type.driver | info:eu-repo/semantics/bachelorThesis | eng |
dc.type.spa | Trabajo de grado - pregrado | spa |
dcterms.references | Jaramillo Claudia. Consenso Colombiano para el Diagnóstico y Tratamiento de la Insuficiencia Cardiaca Crónica [Internet]. Vol. 1, Sociedad colombiana de cardiología y cirugía cardiovascular. 2014 [cited 2020 March 17]. 50 p. Available from: http://scc.org.co/wp-content/uploads/2015/01/cronica-completa-web.pdf | spa |
dcterms.references | Gómez E. Capítulo 2. Introducción, epidemiología de la falla cardiaca e historia de las clínicas de falla cardiaca en Colombia. Rev Colomb Cardiol [Internet]. 2016 Mar 1 [cited 2019 Sep 21];23:6–12. Available from: https://www.sciencedirect.com/science/article/pii/S0120563316000085 | spa |
dcterms.references | Kannel WB, Ho K TT. Changing epidemiological features of cardiac failure. BrHear J. 1994;(2 Suppl):72. | eng |
dcterms.references | Guadalupe J, Canive T, Canive T. Enfoque y características del Método Cuantitativo | Sinnaps [Internet]. Gestor de proyectos online. [cited 2019]. | spa |
dcterms.references | Barreto AC, Nobre MR, Wajngarten M, Canesin MF, Ballas D S-AJ. Insuficiencia cardıaca em grande hospital terciario de Sao Paulo. Arq Bras Cardiol. 1998;71:15–20. | spa |
dcterms.references | Freitas HFG, Chizzola PR, Paes AT, Lima AC MA. Risk stratification in a Brazilian hospitalbased cohort of 1220 outpatients with heart failure: role of Chagas’ heart disease. Int J Cardiol. 2005;102:239–47 | eng |
dcterms.references | Jordán AJ, García M, Monmeneu J V, Reyes F, Climent V, García de Burgos F. Evaluación de tres cuestionarios de actividad en pacientes con insuficiencia cardíaca. Rev Española Cardiol [Internet]. 2003 Jan [cited 2020 May 31];56(1):100–3. Available from: http://www.revespcardiol.org/cgibin/wdbcgi.exe/cardio/mrevista_cardio.fulltext?pident=13042348 | spa |
dcterms.references | Health N, Epi- NES. Risk Factors for Congestive Heart Failure in US Men and Women. 2001;161. | eng |
dcterms.references | Lewis EF. Are Hospitalizations for Heart Failure the Great Equalizer? ∗. JACC Hear Fail [Internet]. 2015 Jul 1 [cited 2019 Jul 10];3(7):539–41. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213177915002176 | eng |
dcterms.references | Piotr Ponikowski. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Rev Española Cardiol [Internet]. 2016 [cited 2019 Ago 15];85. Available from: https://sahta.com/docs/secciones/guias/guiaEscInsuficienciaCardiaca.pdf | spa |
dcterms.references | Zannad F, Jaarsma T, Anker SD, Fonseca C, Køber L, Rønnevik PK, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart. Eur Heart J [Internet]. 2012;33(14):1787–847. Available from: http://eurheartj.oxfordjournals.org/cgi/doi/10.1093/eurheartj/ehs104\npapers3:// publication/doi/10.1093/eurheartj/ehs104 | eng |
dcterms.references | Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and t. J Am Soc Echocardiogr. 2010 Jul;23(7):685-713-8. | eng |
dcterms.references | Henao C, Benavides J, Chaves W, Diaztagle J, Sprokel J, Hernández J. Falla cardíaca descompensada: estratificación del riesgo de mortalidad intrahospitalaria hospital de San José de Bogotá DC. [Internet]. Revistas.fucsalud.edu.co. 2019 [cited 4 May 2019]. Available from: https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/782 | spa |
dcterms.references | Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O’Connor CM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: An analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28(8):980–8. | eng |
dcterms.references | Sato N, Gheorghiade M, Kajimoto K, Munakata R, Minami Y, Mizuno M, et al. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND Registry). Am J Cardiol [Internet]. 2013;111(7):1019–25. Available from: http://dx.doi.org/10.1016/j.amjcard.2012.12.019. | eng |
dcterms.references | Gattis W a, Connor CMO, Adams KF, Elkayam U, Barbagelata A, Benza RL, et al. Effects of Tolvaptan ,. Heart Fail. 2004;291(16):1963–71. | eng |
dcterms.references | Kasper D, Fauci A, Stephen H, Longo D, Jameson JL, Loscalzo J, editors. Harrison. Principios de Medicina Interna [Internet]. 19 ed. Madrid: McGraw Hill; 2016 [citado 20 nov 2019]. Disponible en: http://harrisonmedicina.mhmedical.com/book.aspx?bookid=1717 | spa |
dcterms.references | Balaguer D. Sodio y mortalidad en la insuficiencia cardiaca [Internet]. Sociedad Española de Cardiología. 2012 [cited 16 March 2019]. Available :https://secardiologia.es/blog/4403-sodio-mortalidad-insuficiencia-cardica | spa |
dcterms.references | Diaztagle-Fernández JJ, Chaves-Saltiago WG, Sprockel-Díaz JJ, Acevedo-Velasco AD, Rodríguez-Benítez FH, Benavides-Solarte MF, et al. Asociación entre hiponatremia, mortalidad y estancia hospitalaria en pacientes con falla cardíaca descompensada. MedUNAB [Internet]. 2019 Nov 29 [cited 2020 Feb 10];22(3):294–303. Available from: https://revistas.unab.edu.co/index.php/medunab/article/view/3497 | spa |
dcterms.references | Sayago-Silva I, García-López F, Segovia-Cubero J. Epidemiology of heart failure in Spain over the last 20 years. Rev española Cardiol. 2013 Aug;66(8):649–56 | eng |
dcterms.references | Ospina A. Características clínicas y epidemiológicas de la insuficiencia cardiaca en el Hospital Universitario Ramón Gonzalez Valencia de. Salud UIS. 2004;125–31 | spa |
dcterms.references | Arrigo M, Tolppanen H, Sadoune M, Feliot E, Teixeira A, Laribi S, et al. Effect of precipitating factors of acute heart failure on readmission and long-term mortality. ESC Heart Fail [Internet]. 2016;3(2):115–21. Available from: http://doi.wiley.com/10.1002/ehf2.12083 | eng |
dcterms.references | Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure. Insights From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008;52(5):347–56. | eng |
dcterms.references | WG, Diaztagle JJ, Sprockel JJ, Hernández JI, Benavidez JM, Henao DC, et al. Factors associated with mortality in patients with decompensated heart failure. Acta Chaves Medica Colomb. 2014;39(4):314–20. | eng |
dcterms.references | Sato N, Kajimoto K, Asai K, Mizuno M, Minami Y, Nagashima M, et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: Rationale, design, and preliminary data. Am Heart J [Internet]. 2010;159(6):949–955.e1. Available from: http://dx.doi.org/10.1016/j.ahj.2010.03.019 | eng |
dcterms.references | Kearney MT, Fox KAA, Lee AJ, Prescott RJ, Shah AM, Batin PD, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol. 2002;40(10):1801–8 | eng |
dcterms.references | Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality. Julio Núñez, PhD* Antoni Bayés-Genís, PhD* Faiez Zannad, PhD Patrick Rossignol, PhD.Circulation. tomado de: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.030576 | spa |
dcterms.references | Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol. 2006;47(1):76–84. | spa |
dcterms.references | Walter Gabriel. Cumplimiento de guías en pacientes hospitalizados con falla cardiaca. Redalyc [Internet]. 2014 [cited 2020 Jun 10];39:40–5. Available from: https://www.redalyc.org/pdf/1631/163130905010.pdf | spa |
dcterms.references | Álvarez Frías MT, Gutiérrez Dubois J, Alonso Martínez JL, Solano Remírez M, González Arencibia C, Etxegaray Agara M. Anales de medicina interna. Internet . ol. 22, Anales de Medicina Interna. Ar n diciones, S.A; 2005 [cited 2020 Mar 10]. 309–312 p. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-71992005000700002 | spa |
dcterms.references | Mendez-Bailn M, Barba-Martn R, De Miguel-Yanes JM, Zapatero-Gaviria A, Calvo-Porqueras B, Osuna MFZ, et al. Hyponatremia in hospitalised patients with heart failure in internal medicine: Analysis of the Spanish national minimum basic data set (MBDS) (2005-2011). Eur J Intern Med [Internet]. 2015;26(8):603–6. Available from: http://dx.doi.org/10.1016/j.ejim.2015.06.009 | spa |
oaire.version | info:eu-repo/semantics/acceptedVersion | eng |
sb.programa | Medicina | spa |
sb.sede | Sede Barranquilla | spa |